Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Embedded Chondroitinase ABC Shows Promise for Spinal Injury Treatment

AMSBIO, a leading global supplier of Chondroitinase ABC enzyme, reports on the recent publication by Hu et al.** of the therapeutic efficacy of microtube-embedded Chondroitinase ABC on a group of dogs with naturally occurring spinal injuries.

Read the rest of entry »

The Oxford Science Park sponsors the OXBA Innovation Award for the fourth year . Apply now to be recognised as one of Oxfordshire’s best businesses.

The Oxford Science Park sponsors the OXBA Innovation Award for the fourth year . Apply now to be recognised as one of Oxfordshire’s best businesses.

Read the rest of entry »

Article on In Vitro Methods Published in IBI

Wickham Laboratories are excited to announce their most recent publication on “The Importance of Testing for Pyrogens in Raw and In-Process Materials”, written by Section Head of Endotoxin and Cytotoxicity Testing, Sophie Bell.

Read the rest of entry »

CHAIN Awarded EuropaBio Membership

NOTTINGHAM, UK. — January 9th, 2019 — CHAIN has joined EuropaBio as a full member after placing runner-up in the Biotech SME Awards announced in November. As part of this membership, CHAIN gains access to EuropaBio’s network and will receive updates from working groups operating in diverse areas such as IP, regulatory policy and personalised medicine.

Read the rest of entry »

Arecor to participate at PepTalk 2019's Protein Science Week in San Diego, CA, USA

Arecor Limited, the UK-based leading formulation technology company,, is pleased to announce its participation at PEPTalk 2019’s Protein Science Week.  This leading international conference and one of the largest annual gatherings of over 1,300 protein science researchers in the world, will be held between January 14-18, 2019, at the Hilton Hotel, San Diego Bayfront, San Diego, California, USA.  

Read the rest of entry »

MHRA Inspection success for Nottingham’s Upperton Pharma Solutions

Upperton Pharma Solutions’ new pharmaceutical manufacturing facilities at Nottingham Science and Technology Park have successfully passed inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Read the rest of entry »

Arecor announces clinical trials application to conduct a phase 1 clinical trial

Arecor Ltd, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, is pleased to announce that the Company has filed a Clinical Trial Application (“CTA”) to conduct a Phase I study in Type 1 patients of its ultra-rapid acting insulin product, AT247.   This novel formulation of prandial insulin is designed to deliver an acceleration of insulin absorption post injection.

Read the rest of entry »

OBN Appoints New Chairman and Non-Executive Director to Enhance Board Expertise

OBN, the membership organisation supporting the UK’s innovative life sciences companies, announces changes to its Board including the appointment of Bill Fleming as the new Chairman and the appointment of David Browning.

Read the rest of entry »

First production and administration of Axumin® (fluciclovine (18F)) in France

Blue Earth Diagnostics, a leading molecular imaging diagnostics company, yesterday announced that the first commercial production of Axumin® (fluciclovine (18F)) in France occurred recently, with the first French patients being dosed.  Axumin is a novel molecular imaging agent approved in the European Union for use in PET imaging to detect and localize prostate cancer in men experiencing suspected recurrence based on elevated blood prostate specific antigen (PSA) levels after primary curative treatment.

Read the rest of entry »

Arecor to attend the 37th Annual J.P. Morgan Healthcare Conference

Arecor Ltd, the UK-based specialty pharmaceutical company that develops superior biopharmaceuticals through the application of an innovative formulation technology platform, is pleased to announce today that its executive management team, Dr Sarah Howell (Chief Executive Officer) and Dr Jan Jezek (Chief Scientific Officer) will be attending the 37th Annual J.P. Morgan Healthcare Conference, San Francisco, CA.  

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.